New Brand, Same Neurotherapeutic Clinical Trial Experts
Since day one, Clinilabs has been committed to one thing: advancing the development of central nervous system (CNS) drugs, devices, and technologies to get them to the people who need them most. That singular focus has shaped who we are and how we operate. It drives our scientific curiosity, our operational precision, our relentless dedication to quality — and now, our new brand.
We’re cementing our position as the CRO for CNS and your pathway to CNS approval, with new visuals and messaging. This evolution highlights our indication-level CNS expertise, commitment to quality, and highly personalized client experience as well as our efficiency, agility, and team of specialized experts.
Clinilabs brings together some of the most experienced minds in CNS research, forming an A team that works passionately and collaboratively to make a real difference for every trial we take on.
Our new brand builds on the strong foundation we’ve been crafting for over a quarter of a century. It’s rooted in our commitment to advancing neurotherapeutic development with precision and humanity. Today, we reflect on this legacy and reinforce our promise to deliver comprehensive CNS clinical trial solutions defined by scientific integrity, operational excellence, and personal dedication. We remain your trusted CRO for CNS — turning complexity into clarity and unlocking progress from potential.
Why Now?
CNS development is facing ever-increasing clinical and regulatory pressures: success rates have shrunk, protocols are more complex, and digital biomarkers, AI, and combination therapies demand domain-level expertise. Generalist CROs can’t keep up with the specific demands of CNS trials.
Now more than ever, sponsors need a partner who lives and breathes neuroscience. Our rebrand doubles down on our distinction as the CRO for CNS, making it easier for sponsors to find a reliable pathway to CNS approval and get their therapies to the people who need them.
What the Pathway to CNS Approval Means for Sponsors
CNS is all we do. Every trial is an opportunity to advance science and improve the lives of people living with mental health, neurological, rare, and substance use disorders with our comprehensive services:
-
Phase 2-3 Trial Management
Integrated coordination across sites to ensure consistent execution and high-quality data.
-
Clinical Research Units
Expertly run Phase 1 specialty units for complex first-in-human studies, CNS biomarkers, MedTech verification, validation studies, and more.
-
Early Phase Development
Designed to expedite the development of CNS therapies, medications, and devices, our clinical trial management services are the high-quality, timely, and cost-effective solutions you need.
-
Clinical Trial Services & Technology
Full-service solutions from startup to closeout, tailored to the complexity of CNS research.
-
Corelabs
Centralized data capture and processing to reduce variability and produce clear, actionable data.
-
Advisory & Regulatory
Therapeutic-aligned strategy to guide smarter development plans and speed approvals.
Every decision we make and action we take underscores our steadfast commitment to our mission of providing high-quality, prompt, and cost-effective drug and device development services in the interest of delivering new therapeutics to those in need.
We lead with clarity, confidence, and compassion, living our values of quality, compliance, and excellence in every task because for us, this work is personal.
What Comes Next?
Our new brand is more than new colors or updated photos. It’s a declaration of what’s next for Clinilabs. We’re expanding on decades of neurotherapeutic triumphs to build something bigger than any one trial. We’re advancing CNS care, one breakthrough at a time.
